"It remains to be seen whether Congress would pass legislation allowing HHS to negotiate pricing with manufacturers on behalf of the millions of group and individual health plans throughout the United States.... Continued expansion of drug importation could have a positive effect on cost reduction more widely.... [E]xpansion of biosimilars, expansion in 340(b) hospital programs and other reforms long championed by Rx reformers could lead to a broader impact on prescription drug pricing."  MORE >>